Formosa Pharmaceuticals, Inc. (TPE:6838)
27.85
-0.30 (-1.07%)
At close: Mar 2, 2026
Formosa Pharmaceuticals Revenue
Formosa Pharmaceuticals had revenue of 911.00K TWD in the quarter ending September 30, 2025, a decrease of -78.98%. This brings the company's revenue in the last twelve months to 12.16M, down -91.15% year-over-year. In the year 2024, Formosa Pharmaceuticals had annual revenue of 143.36M with 359.89% growth.
Revenue (ttm)
12.16M
Revenue Growth
-91.15%
P/S Ratio
345.67
Revenue / Employee
n/a
Employees
10
Market Cap
4.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143.36M | 112.18M | 359.89% |
| Dec 31, 2023 | 31.17M | 29.86M | 2,270.49% |
| Dec 31, 2022 | 1.32M | -27.21M | -95.39% |
| Dec 31, 2021 | 28.53M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medigen Biotechnology | 1.59B |
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 424.44M |
| BioGend Therapeutics | 222.34M |
| Pharmosa Biopharm | 136.72M |
| Intech Biopharm | 113.85M |
| ACRO Biomedical | 36.50M |
| UnicoCell Biomed | 34.58M |